Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo
- 283 Downloads
This study describes the preparation and the evaluation of biodegradation monomethoxy (polyethylene glycol)-poly (lactide-co-glycolide)-monomethoxy (polyethyleneglycol) (mPEG-PLGA-mPEG, PELGE) nanoparticles (PELGE-NP) containing mitoxantrone (DHAQ) as a model drug. PELGE copolymers with various molar ratios of lactic to glycolic acid and different molecular weights and various content mPEG were synthesized by ring-opening polymerization. mPEG with weight-average molecular weight (Mw) 2000 or 5000 was introduced as a hydrophilic segment into a hydrophobic PLGA. A double emulsion method with dextran70 as stabilizer in the external aqueous phase was used to prepare the nanoparticles. The drug entrapment efficiencies were more than 80% and the mean diameters of the nanoparticles were less than 200 nm. Various PELGE was studied as biodegradable drug carriers and there in vitro/in vivo release profiles were examined. It was found that drug loading, polymer molecular weight, copolymer composition and end group modifications were critical factors affecting the in vitro/in vivo release properties. The amount of drug released increased as the mPEG contents increased and the molar ratios of lactic acid decreased in vitro. The intravenous (i.v.) administration of mPEG-PLGA–mPEG nanoparticles of DHAQ in mice resulted in prolonged DHAQ residence in systemic blood circulation compared to the intravenous administration of PLGA nanoparticles.
Unable to display preview. Download preview PDF.
- 2.J. Y. YOON, http://www.nanotech.orkr/younjung.doc.04/01/2002.
- 3.S. M. LI, in Degradable Polymers: Principles and Applications (Chapman and Hall, London, 1995) p. 43.Google Scholar
- 5.N. V. MAJETI and R. KUMAR, J. Pharm. Pharmaceut. Sci. 3 (2000) 234.Google Scholar
- 13.R. GREF and R. LANGER, Science 263 (1994) 1600.Google Scholar
- 16.D. BAZILE and M. VEILLARD, J. Pharm. Sci. 84 (1995) 493.Google Scholar